Application 050023

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002MAXITROLDEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATESUSPENSION/DROPS;OPHTHALMIC0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050023-002MAXITROLDEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N050023-002AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N050023-002MAXITROL0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050023-002MAXITROL0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050023-002MAXITROL0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050023-002MAXITROL0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSUSPENSION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982a50c72e98297…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09N050023-002AT1c2088c7a36db…
2026-09-14 22:38:342026-08N050023-002AT184e616aacf4f…
2026-08-18 06:07:402026-07N050023-002AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N050023-002AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050023-002AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N050023-002AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050023-002AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050023-002AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050023-002AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050023-002AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050023-002AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050023-002AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N050023-002AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050023-002AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050023-002AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050023-002AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N050023-002AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050023-002AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N050023-002AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N050023-002AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N050023-002AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N050023-002AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N050023-002AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N050023-002AT187673890dc5c…
2021-03-12 10:30 UTC2021-03N050023-002AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N050023-002AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N050023-002AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N050023-002AT13f01610625f2…
2019-09-15 20:21 UTC2019-09N050023-002AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07N050023-002AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N050023-002AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N050023-002AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N050023-002AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N050023-002AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N050023-002AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N050023-002AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N050023-002AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05N050023-002AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01N050023-002AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N050023-002AT13a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MaxitrolNEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONEHarrow Eye, LLCecfb954f-5554-0ad2-e053-2995a90a75162025-10-24Warnings, Adverse reactionsExact identifier
application applno (NDA): 050023
application number: NDA050023

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0792Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasoneNovartis Pharmaceuticals CorporationNDACurrent
0998-0630Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasoneAlcon Laboratories, Inc.NDACurrent
0998-0630Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasoneAlcon Laboratories, Inc.NDACurrent
0998-0630Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasoneAlcon Laboratories, Inc.NDACurrent
0998-0630Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasoneAlcon Laboratories, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67516SUPPL2021-05-17
67497SUPPL2021-05-17
50790SUPPL2017-12-20
50770SUPPL2017-12-19
48026SUPPL2017-04-14
48004SUPPL2017-04-13
38909SUPPL2008-06-12
7688SUPPL2008-04-28